BioPlx Says It Can Stop Recurrent MRSA Cycles In Hospitals

Would Use Strain Substitution To Prevent Superbugs

Emerging Company Profile: BioPlx
Its non-antibiotic platform aims to control multiple-drug resistant infections • Source: Alamy

More from Business

More from Scrip